Abstract
Infectious disease (ID) cohorts are key to advancing public health surveillance, public policies and pandemic responses. Unfortunately, ID cohorts often lack funding to store and share clinical-epidemiological data (CE) and high-dimensional laboratory (HDL) data long-term, which is evident when the link between these data elements is not kept up to date. This becomes particularly apparent when smaller cohorts fail to successfully address the initial scientific objectives due to limited case numbers, which also limits the potential of pooling for these studies to monitor long-term cross-disease interactions within and across populations. To facilitate advancements in cross-population inference and reuse of cohort data, the European Commission (EC) and the Canadian Institutes of Health Research, Institute of Genetics (CIHR-IG) funded the ReCoDID (Reconciliation of Cohort Data for Infectious Diseases) Consortium to store and share harmonized and standardized CE and HDL data on a federated platform and also provide innovative statistical tools to conduct meta-analyses of the individual patient data. Here we describe the harmonization of CE data from nine arbovirus (arthropod-borne viruses) cohorts in Latin America, which serve as a starting point for the ReCoDID meta-cohort. CE data was retrospectively harmonized using Maelstrom’s methodology and standardized to Clinical Data Interchange Standards Consortium (CDISC).
This meta-cohort will facilitate various joint research projects, e.g., on immunological interactions between sequential flavivirus infections and for the evaluation of potential biomarkers for severe arboviral disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None to disclose
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
none as this was a compilation of research already completed.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Data Availability
Yes, data will be available. We describe this in a particular section of our manuscript.
https://www.ebi.ac.uk/ena/browser/home
